Asset Details
Do you wish to reserve the book?
Cannabinoids in oral fluid by on-site immunoassay and by GC-MS using two different oral fluid collection devices
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Cannabinoids in oral fluid by on-site immunoassay and by GC-MS using two different oral fluid collection devices
Do you wish to request the book?
Cannabinoids in oral fluid by on-site immunoassay and by GC-MS using two different oral fluid collection devices
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Cannabinoids in oral fluid by on-site immunoassay and by GC-MS using two different oral fluid collection devices
2014
Overview
Oral fluid (OF) enables non-invasive sample collection for on-site drug testing, but performance of on-site tests with occasional and frequent smokers’ OF to identify cannabinoid intake requires further evaluation. Furthermore, as far as we are aware, no studies have evaluated differences between cannabinoid disposition among OF collection devices with authentic OF samples after controlled cannabis administration. Fourteen frequent (≥4 times per week) and 10 occasional (less than twice a week) adult cannabis smokers smoked one 6.8 % ∆
9
-tetrahydrocannabinol (THC) cigarette ad libitum over 10 min. OF was collected with the StatSure Saliva Sampler, Oral-Eze, and Draeger DrugTest 5000 test cassette before and up to 30 h after cannabis smoking. Test cassettes were analyzed within 15 min and gas chromatography–mass spectrometry cannabinoid results were obtained within 24 h. Cannabinoid concentrations with the StatSure and Oral-Eze devices were compared and times of last cannabinoid detection (
t
last
) and DrugTest 5000 test performance were assessed for different cannabinoid cutoffs. 11-
nor
-9-Carboxy-THC (THCCOOH) and cannabinol concentrations were significantly higher in Oral-Eze samples than in Stat-Sure samples. DrugTest 5000
t
last
for a positive cannabinoid test were median (range) 12 h (4–24 h) and 21 h (1– ≥ 30 h) for occasional and frequent smokers, respectively. Detection windows in screening and confirmatory tests were usually shorter for occasional than for frequent smokers, especially when including THCCOOH ≥20 ng L
−1
in confirmation criteria. No differences in
t
last
were observed between collection devices, except for THC ≥2 μg L
−1
. We thus report significantly different THCCOOH and cannabinol, but not THC, concentrations between OF collection devices, which may affect OF data interpretation. The DrugTest 5000 on-site device had high diagnostic sensitivity, specificity, and efficiency for cannabinoids.
Publisher
Springer Berlin Heidelberg,Springer,Springer Nature B.V
Subject
/ adults
/ Analysis
/ Analytic Sample Preparation Methods - instrumentation
/ Analytic Sample Preparation Methods - methods
/ Cannabis
/ Characterization and Evaluation of Materials
/ Chemistry and Materials Science
/ Devices
/ drugs
/ Female
/ Fluids
/ gas chromatography-mass spectrometry
/ Gas Chromatography-Mass Spectrometry - methods
/ Humans
/ Male
/ Methods
/ Monitoring/Environmental Analysis
/ Onsite
/ Saliva
/ Smoking
/ THC
